These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1378634)

  • 1. Influences of cyclooxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice.
    Ono N; Abiru T; Sugiyama K; Kamiya H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):59-63. PubMed ID: 1378634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of aspirin on haloperidol-induced cataleptic behavior in mice.
    Ono N; Saito R; Abiru T; Matsushita Y; Kamiya H
    Neuropharmacology; 1988 Mar; 27(3):327-9. PubMed ID: 3374771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-induced increases in sensitivity of cataleptic behavior to haloperidol: possible involvement of prostaglandins.
    Joseph JA; Kandasamy SB; Hunt WA; Dalton TK; Stevens S
    Pharmacol Biochem Behav; 1988 Feb; 29(2):335-41. PubMed ID: 3362928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of prostaglandins in cataleptic behavior in rats.
    Ono N; Saito R; Abiru T; Kamiya H; Furukawa T
    Pharmacol Biochem Behav; 1986 Aug; 25(2):463-7. PubMed ID: 3020596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cyclooxygenase inhibitors on haloperidol-induced catalepsy.
    Naidu PS; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):819-22. PubMed ID: 12369252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo.
    Kaneko M; Sato K; Horikoshi R; Yaginuma M; Yaginuma N; Shiragata M; Kumashiro H
    Prostaglandins Leukot Essent Fatty Acids; 1992 May; 46(1):53-7. PubMed ID: 1378633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Batool F; Hasnat A; Haleem MA; Haleem DJ
    Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
    Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of amfonelic acid on the haloperidol- and clozapine-induced increase in extracellular DOPAC in the nucleus accumbens and the striatum.
    Rivest R; Marsden CA
    Synapse; 1992 Jan; 10(1):71-8. PubMed ID: 1371367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions.
    Teismann P; Ferger B
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):337-48. PubMed ID: 10800755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Nov; 430(2-3):295-8. PubMed ID: 11711046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
    Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
    Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.